Product Images Bicalutamide

This is a medication with the National Drug Code (NDC) 60429-177-01, containing Bicalutamide USP 50mg in tablet form. The dosage information is available in the accompanying prescribing information, and it is important to keep the medication out of reach of children. The pharmacist should dispense the patient information along with the medication, which can be printed from https://gsms.us/. The medication should be stored at a controlled room temperature of 20°C-25°C. The manufacturer is Intas Pharmaceuticals Limited, and the medication is marketed by GSMS, Incorporated in Camarillo, CA, USA.*

This is a table showing four different values (0.3, 0.2, 0.1, 0.0) and two treatments (Bicalutamide plus LHRH-A, Flutamide plus LHRH-A) for a specific medical condition. The table also includes a list of days (365, 730, 1095, 1460, 1825) and a heading indicating "Days to death". However, without more context, it is difficult to determine exactly what the table represents or what the values mean.*

This appears to be a table or graph comparing two treatments for a medical condition using the drugs Bicalutamide and Flutamide in combination with LHRH agonists. The table shows the percentage of patients who did not experience disease progression over a period of up to 1825 days (5 years) on each treatment. However, without more context or a clear indication of what condition is being treated, this information is not very useful.*